Upfront Diagnostics is a Cambridge-based healthcare company focused on discovering novel biomarkers for medical diagnosis. It has developed LVOne, a point-of-care rapid blood test designed to detect large vessel occlusion (LVO) strokes within 15 minutes to help paramedics and community health professionals identify stroke out of hospital. LVOne was validated on 270 patients at the Royal Victoria Infirmary Hospital in Newcastle. The company intends to use the £1.6m seed funding to scale its technology, improve the test's accuracy for identifying large artery strokes, expand its team and prepare for clinical approval. Detecting LVO in the ambulance allows patients to be fast-tracked to thrombectomy-specialized hospitals for rapid imaging and surgical intervention, which can save lives and reduce severity of disability. Development of the test has been supported by Innovate UK, Newcastle University, the Academic Health Science Network, NIHR, SBRI Healthcare, the Stroke Association and NHS Foundation Trust.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2023